Literature DB >> 32313384

Purification of Bionanoparticles.

L Pedro1, S S Soares1, G N M Ferreira1.   

Abstract

The recent demand for nanoparticulate products such as viruses, plasmids, protein nanoparticles, and drug delivery systems have resulted in the requirement for predictable and controllable production processes. Protein nanoparticles are an attractive candidate for gene and molecular therapy due to their relatively easy production and manipulation. These particles combine the advantages of both viral and non-viral vectors while minimizing the disadvantages. However, their successful application depends on the availability of selective and scalable methodologies for product recovery and purification. Downstream processing of nanoparticles depends on the production process, producer system, culture media and on the structural nature of the assembled nanoparticle, i.e., mainly size, shape and architecture. In this paper, the most common processes currently used for the purification of nanoparticles, are reviewed.
Copyright © 2008 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim.

Keywords:  Bionanoparticles; Downstream processing; Gene therapy

Year:  2008        PMID: 32313384      PMCID: PMC7162033          DOI: 10.1002/ceat.200800176

Source DB:  PubMed          Journal:  Chem Eng Technol        ISSN: 0930-7516            Impact factor:   1.728


  88 in total

Review 1.  Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications.

Authors:  G N Ferreira; G A Monteiro; D M Prazeres; J M Cabral
Journal:  Trends Biotechnol       Date:  2000-09       Impact factor: 19.536

2.  In vitro assembly into virus-like particles is an intrinsic quality of Pichia pastoris derived HCV core protein.

Authors:  Nelson Acosta-Rivero; Armando Rodriguez; Alexis Musacchio; Viviana Falcón; Viana M Suarez; Gillian Martinez; Ivis Guerra; Dalila Paz-Lago; Yanelys Morera; María C de la Rosa; Juan Morales-Grillo; Santiago Dueñas-Carrera
Journal:  Biochem Biophys Res Commun       Date:  2004-12-03       Impact factor: 3.575

Review 3.  Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.

Authors:  Bhawna Gupta; Tatiana S Levchenko; Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2004-12-22       Impact factor: 15.470

4.  Purification of infectious adenovirus in two hours by ultracentrifugation and tangential flow filtration.

Authors:  Hideyo Ugai; Takahito Yamasaki; Megumi Hirose; Kumiko Inabe; Yukari Kujime; Miho Terashima; Bingbing Liu; Hong Tang; Mujun Zhao; Takehide Murata; Makoto Kimura; Jianzhi Pan; Yuichi Obata; Hirofumi Hamada; Kazunari K Yokoyama
Journal:  Biochem Biophys Res Commun       Date:  2005-06-17       Impact factor: 3.575

5.  Screening anion-exchange chromatographic matrices for isolation of onco-retroviral vectors.

Authors:  Teresa Rodrigues; Andreia Carvalho; António Roldão; Manuel J T Carrondo; Paula M Alves; Pedro E Cruz
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-05-11       Impact factor: 3.205

6.  Purification of densonucleosis virus by tangential flow ultrafiltration.

Authors:  David L Grzenia; Jonathan O Carlson; Peter Czermak; Binbing Han; Rachel K Specht; S Ranil Wickramasinghe
Journal:  Biotechnol Prog       Date:  2006 Sep-Oct

7.  Formation of well-defined soluble aggregates upon fusion to MBP is a generic property of E6 proteins from various human papillomavirus species.

Authors:  Katia Zanier; Yves Nominé; Sebastian Charbonnier; Christine Ruhlmann; Patrick Schultz; Johannes Schweizer; Gilles Travé
Journal:  Protein Expr Purif       Date:  2006-09-09       Impact factor: 1.650

8.  Purification of capsid-like particles of infectious bursal disease virus (IBDV) VP2 expressed in E. coli with a metal-ion affinity membrane system.

Authors:  Chien-Shiuh Chen; Shing-Yi Suen; Su-Yuan Lai; Gary Ro-Lin Chang; Tsung-Chi Lu; Meng-Shiou Lee; Min-Ying Wang
Journal:  J Virol Methods       Date:  2005-07-22       Impact factor: 2.014

9.  Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells.

Authors:  S E Crawford; M Labbé; J Cohen; M H Burroughs; Y J Zhou; M K Estes
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  Purification, characterization and serological detection of virus-like particles associated with banana bunchy top disease in Australia.

Authors:  J E Thomas; R G Dietzgen
Journal:  J Gen Virol       Date:  1991-02       Impact factor: 3.891

View more
  1 in total

Review 1.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.